Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-02-03 @ 3:39 AM
Study NCT ID:
NCT01915602
Status:
COMPLETED
Last Update Posted:
2021-04-08
First Post:
2013-07-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)
Sponsor:
Organization: